Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.113596287703016 0.112296983758701 0.0580046403712297
Stock impact report

BioSig Completes 100th Patient Case with PURE EP(TM) System

BioSig Technologies, Inc. (BSGM) 
NASDAQ:AMEX Investor Relations: biosigtech.com
Company Research Source: GlobeNewswire
WESTPORT, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Novel Cardiac Signal Processing System BioSig Technologies Inc. at AF Symposium 2020 Commercialization and install plan ahead of scheduleInstallations at new centers are driving patient enrollments and clinical data collection BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company successfully completed 100 patient cases with its PURE Show less Read more
Impact Snapshot
Event Time:
BSGM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BSGM alerts

from News Quantified
Opt-in for
BSGM alerts

from News Quantified